Aldeyra Therapeutics (NASDAQ:ALDX) Downgraded by StockNews.com

StockNews.com lowered shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a hold rating to a sell rating in a research note published on Wednesday. A number of other equities analysts have also weighed in on the company. Oppenheimer reiterated an outperform rating and set a $10.00 target price on shares of Aldeyra Therapeutics in […]

Related Keywords

Los Angeles ,California ,United States ,Ptoddc Brady , ,Los Angeles Capital Management ,Deutsche Bank ,Acadian Asset Management ,Kennedy Capital Management ,Perceptive Advisors Llc ,Aldeyra Therapeutics ,Free Report ,Get Free Report ,Capital Management ,Asset Management ,Angeles Capital Management ,Scavenger Receptor ,Aldeyra Therapeutics Daily ,